Newsletter | April 2, 2025

04.02.25 -- Leveraging Scientific Expertise To Lead

SPONSOR

A Full-Service Solution Partner Disrupting the Outsourcing Paradigm

inSeption Group offers a full-service solution designed to disrupt the current outsourcing paradigm, resurrecting a common-sense approach to rebuild business trust and confidence in a client’s selected vendor. Primarily focused on oncology, hematology, neurodegenerative disorders, and rare/orphan disease indications, with a specialization in cell and gene therapy, inSeption has been a solution for its’ clients who have experienced the progressive degradation of today’s outsourcing options. Contact them.

FEATURED PODCAST

How Rick Modi Leverages Scientific Expertise To Lead Affinia Therapeutics

Rick Modi’s background in pharmacy gave him the scientific and analytical chops to pursue an MBA and ultimately lead innovative gene therapy companies.

INDUSTRY INSIGHTS

Navigating The Complexities Of Publication Planning

In the dynamic landscape of the life sciences industry, Medical Affairs (MA) teams and accessible digital platforms are pivotal in navigating the complexities of medical publication planning.

Identifying The Right Analytical Strategy For AAV Production

AAV has become an increasingly popular vector for gene therapy applications, yet ongoing challenges related to process and analytical development often require significant expertise to navigate.

Innovative Approaches In Oncology Clinical Trials

By embracing innovative trial models and strategic collaborations, oncology CROs play a pivotal role in bringing novel cancer therapies to market efficiently and effectively.

Cost Of Ownership: Cloud vs. On-Premises In The Pharmaceutical Industry

Many pharmaceutical companies are considering implementing cloud solutions to address the growing complexity of traditional clinical trials, fragile supply chains, and increasing regulatory pressures.

Is Sustainability The Key To Agile Biopharma Manufacturing?

Discover how new innovations and a focus on sustainability have gotten 62% of executives to prioritize eco-friendly practices, which reflects a commitment to long-term viability.